6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
7m ago	ProWood TrueFrame Joist Now Available Across Northeast, South Atlantic
8m ago	Parker to Acquire CIRCOR’s Commercial and Defense Aerospace Business
8m ago	Toll Brothers Announces Cedar Terrace Community Now Open in Chantilly, Virginia
8m ago	When Blood Compatibility Becomes a Pregnancy Risk
8m ago	Tony and Grammy Award-Winning Leslie Odom, Jr. to Headline Blackbaud's bbcon 2026 Social Impact Tech Conference

About

15.74USD-0.16 -1.01%

Closed • Updated at 13:55 GMT+00:00

Market Cap$2.02B

P/E Ratio7.27

Volume180.3K

Beta0.15

RSI51.07

Gross Margin89.74%

Health TechnologyBiotechnology

Aurinia Pharmaceuticals Inc — investor relations, events, news, and company updates on 6ix.

Latest News

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right

Aurinia Announces Management Transition

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress

Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026

Community Chat

Ask AI